Showing 11-19 of 19 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Manufacturing high quality cGMP-compatible SC-islets | University Health Network | Maria Cristina Nostro | Cures | 01-May-2025 to 31-March-2027 | $1,498,919.50 |
| Type 1 Diabetes TrialNet Canadian Network | The Hospital for Sick Children | Diane Wherrett | Cures | 01-June-2026 to 31-May-2031 | $199,995.00 |
| Development of targeted nanoparticles for delivering therapeutics to islet cells for treatment of T1D | The Governing Council of the University of Toronto | Xiao Yu (Shirley) Wu | Cures | 01-April-2023 to 31-March-2027 | $899,710.00 |
| Synthetic vascularizing biomaterial platform for subcutaneous islet transplantation and immunomodulation | The Governing Council of the University of Toronto | Sean Kinney | Cures | 01-March-2025 to 29-February-2028 | $237,690.00 |
| Picosecond Infrared Laser (PIRL)-based spatial imaging mass spectrometry (proteomics) and transcriptomics of beta-cells in live human pancreas slices afflicted by T1D T-cell immune injury | The Governing Council of the University of Toronto | Herbert Gaisano | Cures | 01-April-2026 to 31-March-2027 | $199,430.00 |
| mRNA/LNP-based Epigenetic Immunomodulation to Restore Tolerance in T1D | The Governing Council of the University of Toronto | BOWEN LI | Cures | 01-April-2026 to 31-March-2027 | $199,998.79 |
| Regenerating Human Pancreatic β Cells to Treat Diabetes | Sunnybrook Research Institute | Robert Screaton | Cures | 01-May-2022 to 31-May-2027 | $900,000.00 |
| Safe and Immune Cloaked Stem Cell-Derived Beta-Cells: Treatment for Type 1 Diabetes Mellitus | Sinai Health System | Andras Nagy | Cures | 01-October-2022 to 30-September-2027 | $1,474,390.51 |
| Clinical Translation of Allarta’s Immune-Protective Hydrogel Encapsulation for Islet Transplantation in T1D | Allarta Life Science | Harald Stover | Cures | 15-June-2026 to 14-June-2029 | $3,000,000.00 |